Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice

OBJECTIVE: Obesity is a major health threat that affects men and women equally. Despite this fact, weight-loss potential of pharmacotherapies is typically first evaluated in male mouse models of diet-induced obesity (DIO). To address this disparity we herein determined whether a monomeric peptide wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jall, Sigrid, Sachs, Stephan, Clemmensen, Christoffer, Finan, Brian, Neff, Frauke, DiMarchi, Richard D., Tschöp, Matthias H., Müller, Timo D., Hofmann, Susanna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404097/
https://www.ncbi.nlm.nih.gov/pubmed/28462078
http://dx.doi.org/10.1016/j.molmet.2017.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404097/
https://www.ncbi.nlm.nih.gov/pubmed/28462078
http://dx.doi.org/10.1016/j.molmet.2017.02.002

Ejemplares similares